Authors: Shahidi, M Norman, AR Gadd, J Huddart, RA Horwich, A Dearnaley, DP

Citation: M. Shahidi et al., Recovery of serum testosterone, LH and FSH levels following neoadjuvant hormone cytoreduction and radical radiotherapy in localized prostate cancer, CL ONCOL-UK, 13(4), 2001, pp. 291-295

Authors: Patterson, H Norman, AR Mitra, SS Nicholls, J Fisher, C Dearnaley, DP Horwich, A Mason, MD Huddart, RA

Citation: H. Patterson et al., Combination carboplatin and radiotherapy in the management of stage II testicular seminoma: comparison with radiotherapy treatment alone, RADIOTH ONC, 59(1), 2001, pp. 5-11

Authors: Andreyev, HJN Norman, AR Cunningham, D Oates, J Dix, BR Iacopetta, BJ Young, J Walsh, T Ward, R Hawkins, N Beranek, M Jandik, P Benamouzig, R Jullian, E Laurent-Puig, P Olschwang, S Muller, O Hoffmann, I Rabes, HM Zietz, C Troungos, C Valavanis, C Yuen, ST Ho, JWC Croke, CT O'Donoghue, DP Giaretti, W Rapallo, A Russo, A Bazan, V Tanaka, M Omura, K Azuma, T Ohkusa, T Fujimori, T Ono, Y Pauly, M Faber, C Glaesener, R de Goeij, AFPM Arends, JW Andersen, SN Lovig, T Breivik, J Gaudernack, G Clausen, OPF De Angelis, P Meling, GI Rognum, TO Smith, R Goh, HS Font, A Rosell, R Sun, XF Zhang, H Benhattar, J Losi, L Lee, JQ Wang, ST Clarke, PA Bell, S Quirke, P Bubb, VJ Piris, J Cruickshank, NR Morton, D Fox, JC Al-Mulla, F Lees, N Hall, CN Snary, D Wilkinson, K Dillon, D Costa, J Pricolo, VE Finkelstein, SD Thebo, JS Senagore, AJ Halter, SA Wadler, S Malik, S Krtolica, K Urosevic, N

Citation: Hjn. Andreyev et al., Kirsten ras mutations in patients with colorectal cancer: the 'RASCAL II' study, BR J CANC, 85(5), 2001, pp. 692-696

Authors: Dearnaley, DP Khoo, VS Norman, AR Meyer, L Nahum, A Tait, D Yarnold, J Horwich, A

Citation: Dp. Dearnaley et al., Comparison of radiation side-effects of conformal and conventional radiotherapy in prostate cancer: a randomised trial, LANCET, 353(9149), 1999, pp. 267-272

Authors: Dearnaley, DP Norman, AR Shahidi, M

Citation: Dp. Dearnaley et al., Time to normalization of serum testosterone after 3-month luteinizing hormone-releasing hormone agonist administered in the neoadjuvant setting: Implications for dosing schedule and neoadjuvant study consideration, J UROL, 162(1), 1999, pp. 170-170

Authors: Andreyev, HJN Norman, AR Oates, J Cunningham, D

Citation: Hjn. Andreyev et al., Comments on: Why do patients with weight loss have a worse outcome when undergoing chemotherapy for gastrointestinal malignancies, Andreyev et al, Eur J Cancer 1998, 34, pp. 503-509 - Response from H.J.N. Andreyev, A.R. Norman, J. Oates and D. Cunningham, EUR J CANC, 34(13), 1998, pp. 2133-2133